Skip to content
Disclosery

MRA Advisory Group: BE position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of MRA Advisory Group on BE, newest first. How the timeline and the estimate are built.

MRA Advisory Group held 9,373 BE shares at 2026-09-30 per its 13F-HR filed 2026-10-07.

the latest 13F is the newest step

  1. period ended2026-09-30
    13F 9,373 shares
    Change vs previous 13F -823 shares

    0.97% of the 13F portfolio, value $2,596,003.

    13F-HR 0001841816-26-000007 filed by MRA Advisory Group
    Accepted , ingested

  2. period ended2026-06-30
    13F 10,196 shares
    Change vs previous 13F +4,750 shares

    1.12% of the 13F portfolio, value $3,086,274.

    13F-HR 0001841816-26-000003 filed by MRA Advisory Group
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2026-03-31
    13F 5,446 shares
    Change vs previous 13F +237 shares

    0.3% of the 13F portfolio, value $737,855.

    13F-HR 0001841816-26-000002 filed by MRA Advisory Group
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-12-31
    13F 5,209 shares
    Change vs previous 13F +5,209 shares

    0.19% of the 13F portfolio, value $452,633.

    13F-HR 0001841816-26-000001 filed by MRA Advisory Group
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 0 shares
    Change vs previous 13F -19,019 shares

    13F-HR 0001841816-25-000003 filed by MRA Advisory Group
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  6. period ended2025-03-31
    13F 19,019 shares
    Change vs previous 13F not available

    0.2% of the 13F portfolio, value $373,912.

    13F-HR 0001841816-25-000002 filed by MRA Advisory Group
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).